The FDA has granted New York-based Smart Meter 510(k) clearance for its iGlucose blood glucose monitoring system, a subscription-free glucose meter and diabetes health management platform that allows for automatic transmission of data to a cloud-based personalized web portal. The system, which enables diabetes patients to have real-time communication with their caregivers, has also received CE mark approval from European regulators.
FDA, EU approve Smart Meter's glucose monitoring system
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.